期刊文献+

Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma 被引量:9

Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma
暂未订购
导出
摘要 Cholangiocarcinoma is the second most common primary hepato-biliary malignancy. The majority of patients with primary hepatic tumors are not suitable candidates for resection, due to advanced stage of the disease at presentation, anatomic limitations and medical comorbidities. At present, radiofrequency ablation (RFA) may offer an alternative, feasible and safe therapy for selected patients with hepatic tumors, who are not otherwise candidates for hepatic resection. Herein, we present the case of successful RFA in a patient with a solitary, primary intrahepatic cholangiocarcinoma. The patient remained free of disease 24 mo after the procedure, and is still followed up. This is the first report of RFA application inthe treatment of primary intrahepatic cholangiocarcinoma. Cholangiocarcinoma is the second most common primary hepato-biliary malignancy. The majority of patients with primary hepatic tumors are not suitable candidates for resection, due to advanced stage of the disease at presentation, anatomic limitations and medical comorbidities. At present, radiofrequency ablation (RFA) may offer an alternative, feasible and safe therapy for selected patients with hepatic tumors, who are not otherwise candidates for hepatic resection. Herein, we present the case of successful RFA in a patient with a solitary, primary intrahepatic cholangiocarcinoma. The patient remained free of disease 24 mo after the procedure, and is still followed up. This is the first report of RFA application in the treatment of primary intrahepatic cholangiocarcinoma.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第33期5239-5240,共2页 世界胃肠病学杂志(英文版)
关键词 CHOLANGIOCARCINOMA Radiofrequency ablation Hepatic tumor 射频消融 肝肿瘤 治疗方法 鉴别诊断
  • 相关文献

参考文献5

  • 1American cancer society.What are the key statistics for bile duct cancer?Available at:www.cancer.org.
  • 2Shaib Y,El-Serag HB.The epidemiology of cholangiocancinoma.Semin Liver Dis 2004,24:115-125.
  • 3Curley SA,Izzo F,Delrio P,Ellis LM,Granchi J,Vallone P,Fiore F,Pignata S,Daniele B,Cremona F.Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies:results in 123 patients.Ann Surg 1999,230:1-8.
  • 4Curley SA,Izzo F,Ellis LM,Nicolas Vauthey J,Vallone P.Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrosis.Ann Surg 2000,232:381-391.
  • 5Allgaier HP,Deibert P,Zuber I,Olschewski M,Blum HE.Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular cancinoma.Lancet 1999,353:1676-1677.

同被引文献129

引证文献9

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部